Grow Group Secures Multimillion-Pound Refinancing Pivot After Sale Efforts
UK medicinal cannabis firm Grow Group has secured new financing while exiting sale mode, marking a strategic shift for the alcohol-free healthcare sector.
POLICY WIRE — London, UK — Medicinal cannabis company Grow Group has finalized a refinancing package worth several million pounds, a decisive move that departs from an earlier plan to completely divest the business.
The firm, established in 2017, manufactures and distributes medical cannabis products across the United Kingdom and two additional international markets.
Initially, the company engaged financial advisors to locate new ownership, a step driven by a noticeable dip in recent revenue figures.
According to reports from Sky News, Grow Group collaborated with the advisory firm Alvarez & Marsal to expedite this potential sale process.
However, the current refinancing deal indicates the company has opted to remain independent rather than undergo a full acquisition.
Reporting by Policy-Wire (PW)
